New York State Common Retirement Fund
SLRN

New York State Common Retirement Fund’s ACELYRIN SLRN Stock Holding History

New York State Common Retirement Fund’s Portfolio SLRN Stock Details SLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,512
Closed -$38.3K – 3325
2025
Q1 		$38.3K Hold
15,512
– – ﹤0.01% 2851
2024
Q4 		$48.7K Sell
15,512
-7,305
-32% -$35.4K ﹤0.01% 2860
2024
Q3 		$112K Sell
22,817
-14,600
-39% -$75.4K ﹤0.01% 2531
2024
Q2 		$165K Buy
37,417
+4,988
+15% +$23.4K ﹤0.01% 2507
2024
Q1 		$219K Buy
32,429
+19,248
+146% +$146K ﹤0.01% 2388
2023
Q4 		$98.3K Buy
13,181
+6,032
+84% +$51.5K ﹤0.01% 2753
2023
Q3 		$72.7K Buy
+7,149
New +$152K ﹤0.01% 2885

Other funds holding SLRN

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

New York State Common Retirement Fund's SLRN Position: Q2 2025 in Review

New York State Common Retirement Fund sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 15,512 shares — an estimated $38.3K sold.

New York State Common Retirement Fund first reported a position in SLRN in Q3 2023 and held it in 7 quarters. The position peaked at $219K in Q1 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • New York State Common Retirement Fund reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • New York State Common Retirement Fund sold 15,512 ACELYRIN shares in Q2 2025, an estimated $38.3K.
  • New York State Common Retirement Fund first reported a position in ACELYRIN in Q3 2023 and held it in 7 quarters.
  • New York State Common Retirement Fund's ACELYRIN position peaked at $219K in Q1 2024.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on New York State Common Retirement Fund's 13F filing for Q2 2025, filed 13 Aug 2025.